Jeonjinbio

110020 · KOSDAQ · ₩110020 · 전진바이오팜

₩2,050 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩14B₩19B₩16B₩7.8B₩3.2B
Cost of sales₩9.9B₩13B₩11B₩5.8B₩1.9B
Gross profit₩3.8B₩6.1B₩4.9B₩2B₩1.4B
Operating income−₩343M₩1.2B−₩1.2B−₩3.2B−₩3B
Net income−₩196M₩4.3B−₩6.4B−₩3.2B−₩2.1B
Net income to shareholders−₩196M₩4.3B−₩6.4B−₩3.2B−₩2.1B

Balance sheet

20252024202320222021
Total assets₩19B₩19B₩18B₩18B₩25B
Current assets₩9.5B₩10B₩7.8B₩4.7B₩16B
Cash and equivalents₩6.4B₩6.3B₩1.7B₩1.3B₩15B
Total liabilities₩1.1B₩1.2B₩11B₩8.4B₩14B
Current liabilities₩875M₩1.1B₩11B₩7.9B₩14B
Borrowings₩0₩0₩9.1B₩6B₩13B
Total equity₩17B₩18B₩6.2B₩9.5B₩11B
Shareholders' equity₩17B₩18B₩6.2B₩9.5B₩11B

Cash flow

20252024202320222021
Cash from operations₩483M₩3B−₩301M−₩3.7B−₩2.4B
Capital spending₩789M₩389M₩660M₩2B₩1.8B
Free cash flow−₩306M₩2.6B−₩961M−₩5.7B−₩4.2B

Consolidated where available. Amounts in won.

Also known as: Jeonjinbio / 전진바이오팜 / 110020 / KRX:110020

Source: KRX statistical information